Value of Using Pioglitazone in Chronic Myeloid Leukemia Treatment
Conditions: Chronic Myelogenous Leukemia, BCR-ABL Positive; CML, Chronic Phase Intervention: Drug: Pioglitazone 15mg Sponsor: Mansoura University Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials